[1] 冀旭,孟宇,薛泮宏,等.血液灌流联合血液透析对ESRD患者ApoC3、血脂代谢及心脏结构与功能的影响[J].内科急危重症杂志,2017,23(3):233-236. [2] 邹懿,王茜茜,程宗华,等.血液灌流联合维持性血液透析对尿毒症患者心脏结构和功能的作用[J].实用医学杂志,2016,32(20):3321-3324. [3] 许俊,彭红英,冯志鹏,等.血液透析联合血液灌流对维持性血液透析患者感染与钙磷代谢的影响[J].中华医院感染学杂志,2015,27(8):1808-1810. [4] 周进,唐前容,敖利娜,等.血液灌流联合血液透析对尿毒症患者钙磷代谢紊乱和微炎症状态的影响[J].中国老年学杂志,2017,37(16):4062-4065. [5] Loutradis C, Sarafidis PA,Papadopoulos CE,et al.The ebb and flow of echocardiographic cardiac function parameters in relationship to hemodialysis treatment in patients with ESRD[J].J Am Soc Nephrol,2018; 29 (5 ):1372-1381. [6] 张淳,黄灿茂,陈俊华,等.不同血液透析方法影响老年尿毒症患者甲状旁腺激素及钙磷代谢的比较[J].中国老年学杂志,2014,11(18):5130-5131. [7] Takakuwa Y, Sarai M, Kawai H,et al.Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis.[J].J Nucl Med,2018 ; 6 (1 ):1-9. [8] 林明增.血液透析和腹膜透析对尿毒症患者钙磷代谢影响的临床研究[J].中国血液净化,2013,12(9):487-490.